SEDPARK1: Safety and Efficacy Study With the Non-ergot Dopamine-agonist Piribedil in Parkinson's Disease (PIR-001/K)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00725478
Recruitment Status : Completed
First Posted : July 30, 2008
Last Update Posted : March 31, 2010
Information provided by:
Desitin Arzneimittel GmbH